Form 4 Filing for ANAPTYSBIO, INC.

This filing details a transaction by Renton Hollings, a director at ANAPTYSBIO, INC. On June 15, 2026, Hollings was granted 6,030 Restricted Stock Units (RSUs), with each RSU convertible to one share of common stock. These RSUs vest on June 15, 2026, contingent upon continued service to the company. The transaction code "M" and acquisition code "A" for common stock, alongside the grant of RSUs, indicate the acquisition of equity. Post-transaction, Hollings holds 10,995 shares of common stock. The filing also includes a Power of Attorney authorizing specific individuals to act on Hollings' behalf for SEC filings.